11/14/2024 5:01 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 6:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 6:53 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024 1:02 PM | BlackRock, Inc. (Filed by) Intra-Cellular Therapies (Subject)
| Form SC 13G/A | |
10/15/2024 5:00 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2024 11:36 AM | Intra-Cellular Therapies (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SC 13G | |
|
10/02/2024 5:01 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2024 4:43 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 5:01 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 3:06 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024 3:34 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 5:00 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 3:34 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024 3:36 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 5:00 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 3:09 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 5:03 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:00 PM | Intra-Cellular Therapies (Issuer) Narula Sanjeev (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:01 PM | Intra-Cellular Therapies (Issuer) Narula Sanjeev (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 6:55 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024 6:49 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 7:00 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:00 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:04 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:05 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:05 PM | Intra-Cellular Therapies (Issuer) Salas Eduardo Rene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:05 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:28 PM | Intra-Cellular Therapies (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/21/2024 5:00 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 5:00 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 5:01 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 5:02 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 5:02 PM | Intra-Cellular Therapies (Issuer) Salas Eduardo Rene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 6:40 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 6:43 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 3:46 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
04/29/2024 3:48 PM | Intra-Cellular Therapies (Filer)
| Form ARS | |
04/24/2024 3:20 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 4:23 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
04/18/2024 4:25 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024 6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 7:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 7:31 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:32 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:52 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:38 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:44 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:36 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:27 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:04 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:41 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:57 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:22 PM | Intra-Cellular Therapies (Subject) VAN NOSTRAND ROBERT L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:33 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:22 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:42 AM | Intra-Cellular Therapies (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/09/2024 11:40 AM | Intra-Cellular Therapies (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024 5:02 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:07 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:10 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:13 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Trump won. Buy this coin now. (Ad) Juan Villaverde called the top and bottom of every crypto bull market since 2012.
He believes Bitcoin will go to $150,000 — or more.
But there’s one coin he thinks could go even higher. This could be his favorite coin. |
02/02/2024 3:47 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:39 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:41 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 6:47 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 4:08 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 5:02 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 6:54 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:43 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |